How is PCD Diagnosed in Babies and Toddlers?
At a Glance
Primary Ciliary Dyskinesia (PCD) in babies and toddlers under 5 is primarily diagnosed using genetic testing and ciliary biopsies (nasal brushings). The standard nNO breath test is generally ineffective for young children because they cannot perform the required breathing maneuvers.
In this answer
3 sections
When a baby or toddler under age 5 has warning signs of Primary Ciliary Dyskinesia (PCD)—such as unexplained respiratory distress at birth or constant sinus and ear infections—doctors cannot rely on the standard nasal nitric oxide (nNO) breath test. Instead, specialists use a combination of alternative methods, primarily genetic testing and ciliary biopsies, to secure a diagnosis.
Why the Standard nNO Test Doesn’t Work for Toddlers
The standard nasal nitric oxide (nNO) test measures the amount of a gas called nitric oxide in the nasal passages. To get an accurate reading, the patient must perform a velum closure maneuver—which usually means holding their breath or exhaling steadily against resistance [1][2]. Babies and toddlers under 5 simply cannot follow these complex instructions.
Additionally, while older children and adults with PCD have distinctively low nNO levels, even healthy infants have naturally low nNO production shortly after birth. This makes the test much harder to interpret accurately in the youngest patients [3][4]. Some specialized centers can perform a modified version of the test during normal resting breathing (tidal-breathing nNO), but when that isn’t possible or the results are inconclusive, doctors must turn to other tests [1].
How PCD is Diagnosed Under Age 5
Because no single test is 100% perfect, diagnosing PCD requires a “multimodal” approach—putting together pieces of a puzzle using several different tests [5][6]. If your child is too young for the standard nNO test, doctors will typically rely on the following:
1. Genetic Testing
Genetic testing has become a cornerstone of diagnosing PCD, especially in infants and toddlers [7][8]. Using a simple blood or saliva draw, a lab checks for mutations (errors) in the genes known to cause the condition.
- What it does: It looks for the genetic blueprints that cause the cilia to malfunction.
- The benefit: It requires no active cooperation from your child and can identify the exact cause of PCD in about 70% of cases [7][9].
- The limitation: Because researchers haven’t discovered every single gene involved in PCD, a negative genetic test does not entirely rule out the condition [10][11].
2. Ciliary Biopsy (Nasal Brushing)
If genetic testing is inconclusive or unavailable, a doctor may perform a ciliary biopsy. During this procedure, a tiny brush is swept inside the nose to collect a sample of living ciliated cells [12]. For infants and toddlers, this is done while they are awake. They will usually sit in a parent’s lap and be held securely for the few seconds the brushing takes. It can cause brief discomfort, sneezing, or a minor nosebleed, but the procedure is over very quickly.
The sample is sent to a specialized lab for analysis:
- High-Speed Video Microscopy (HSVM): A high-speed camera attached to a microscope records the cilia in real time to see if they are moving too slowly, beating stiffly, or entirely paralyzed [12][13].
- Transmission Electron Microscopy (TEM): The sample is viewed under a powerful electron microscope to look at the physical structure of the cilia. TEM can reveal if critical inner parts of the cilia are missing [14][15]. Limitation: A normal TEM result does not rule out PCD, as up to 30% of patients have structurally normal-looking cilia that still don’t function properly [14].
- Immunofluorescence (IF): Many specialized centers now use special dyes to highlight specific proteins inside the cilia, helping identify defects that TEM might miss [12].
Next Steps and What to Expect
If your child has strong warning signs of PCD, ask for a referral to a specialized PCD or pediatric pulmonology center [16][17].
The timeline: Keep in mind that securing a PCD diagnosis is a process. Analyzing genetic panels and specialized biopsies is highly complex, and it is normal for these test results to take several weeks or even months to come back.
What to do while you wait: Even without a finalized diagnosis, your doctor should immediately treat the symptoms. Ask your care team about starting daily airway clearance techniques (like chest physiotherapy) at home and establishing a proactive plan for aggressively treating sinus, ear, and lung infections.
Common questions in this guide
Why can't the standard nNO test be used to diagnose PCD in babies?
What happens during a nasal brushing for a toddler?
How accurate is genetic testing for diagnosing PCD in children?
What should we do while waiting for my child's PCD test results?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my child's age, can your center perform a tidal-breathing nNO test, or should we move straight to genetic testing?
- 2.If we do a genetic panel, does it cover all the currently known PCD-related genes?
- 3.Would a nasal brushing (ciliary biopsy) be appropriate for my child, and does your lab have experience analyzing pediatric HSVM and TEM samples?
- 4.While we wait for diagnostic results, what airway clearance techniques should we start doing at home to protect their lungs?
- 5.Which specialized PCD diagnostic center do you recommend we consult with?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Infant nasal nitric oxide over time: natural evolution and impact of respiratory tract infection.
Marthin JK, Philipsen MC, Rosthoj S, Nielsen KG
The European respiratory journal 2018; (51(6)) doi:10.1183/13993003.02503-2017.
PMID: 29748307 - 2
Proof of Concept: Very Rapid Tidal Breathing Nasal Nitric Oxide Sampling Discriminates Primary Ciliary Dyskinesia from Healthy Subjects.
Holgersen MG, Marthin JK, Nielsen KG
Lung 2019; (197(2)):209-216 doi:10.1007/s00408-019-00202-x.
PMID: 30762092 - 3
Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia.
Gileles-Hillel A, Mor-Shaked H, Shoseyov D, et al.
ERJ open research 2020; (6(4)) doi:10.1183/23120541.00213-2020.
PMID: 33447612 - 4
Letter to the Editor on "Feasibility of nasal NO screening in healthy newborns".
Beydon N, Lucas JS
Pediatric pulmonology 2022; (57(3)):768-769 doi:10.1002/ppul.25784.
PMID: 35040285 - 5
Diagnosis and management of children with primary ciliary dyskinesia.
Harris A
Nursing children and young people 2017; (29(7)):38-47 doi:10.7748/ncyp.2017.e936.
PMID: 29115761 - 6
Primary Ciliary Dyskinesia-Current Diagnostic and Therapeutic Approach.
Wrona J, Krupa Z, Zawadzka M, et al.
Journal of clinical medicine 2025; (14(19)) doi:10.3390/jcm14196808.
PMID: 41095888 - 7
Genes take the lead: genetic testing becomes the gold standard for diagnosing primary ciliary dyskinesia.
Shapiro AJ, Thornton CS
The European respiratory journal 2024; (64(6)) doi:10.1183/13993003.01888-2024.
PMID: 39667783 - 8
Primary ciliary dyskinesia in the genomics age.
Lucas JS, Davis SD, Omran H, Shoemark A
The Lancet. Respiratory medicine 2020; (8(2)):202-216 doi:10.1016/S2213-2600(19)30374-1.
PMID: 31624012 - 9
Whole-Exome Sequencing and Targeted Copy Number Analysis in Primary Ciliary Dyskinesia.
Marshall CR, Scherer SW, Zariwala MA, et al.
G3 (Bethesda, Md.) 2015; (5(8)):1775-81 doi:10.1534/g3.115.019851.
PMID: 26139845 - 10
Mutations in CFAP47, a previously reported MMAF causative gene, also contribute to the respiratory defects in patients with PCD.
Ge H, Zhou W, He M, et al.
Molecular genetics & genomic medicine 2024; (12(1)):e2278 doi:10.1002/mgg3.2278.
PMID: 37723893 - 11
Primary ciliary dyskinesia: a case report of double DNAH11 mutant alleles.
Pîrlog LM, Pătrăşcanu AA, Kutasi E, et al.
Medicine and pharmacy reports 2025; (98(2)):252-256 doi:10.15386/mpr-2743.
PMID: 40371404 - 12
European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia.
Lucas JS, Barbato A, Collins SA, et al.
The European respiratory journal 2017; (49(1)) doi:10.1183/13993003.01090-2016.
PMID: 27836958 - 13
Evaluation of Open-Source Ciliary Analysis Software in Primary Ciliary Dyskinesia: A Comparative Assessment.
Demetriou ZJ, Muñiz-Hernández J, Rosario-Ortiz G, et al.
Diagnostics (Basel, Switzerland) 2024; (14(16)) doi:10.3390/diagnostics14161814.
PMID: 39202302 - 14
Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline.
Shapiro AJ, Davis SD, Polineni D, et al.
American journal of respiratory and critical care medicine 2018; (197(12)):e24-e39 doi:10.1164/rccm.201805-0819ST.
PMID: 29905515 - 15
Primary ciliary dyskinesia caused by a large homozygous deletion including exons 1-4 of DRC1 in Japanese patients with recurrent sinopulmonary infection.
Keicho N, Hijikata M, Morimoto K, et al.
Molecular genetics & genomic medicine 2020; (8(1)):e1033 doi:10.1002/mgg3.1033.
PMID: 31701675 - 16
Primary ciliary dyskinesia: clinical manifestations and current diagnostic approaches.
Reklow RJ, Weir MJ, Dell SD
Current opinion in pulmonary medicine 2025; (31(6)):635-643 doi:10.1097/MCP.0000000000001213.
PMID: 40916971 - 17
The BEAT-PCD (Better Experimental Approaches to Treat Primary Ciliary Dyskinesia) Clinical Research Collaboration.
Goutaki M, Crowley S, Dehlink E, et al.
The European respiratory journal 2021; (57(2)) doi:10.1183/13993003.04601-2020.
PMID: 33541936
This page provides informational content about diagnosing Primary Ciliary Dyskinesia (PCD) in young children. It does not replace professional medical advice or diagnosis from a qualified pediatric pulmonologist.
Get notified when new evidence is published on Primary ciliary dyskinesia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.